Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 5-Session therapy ease student stress? new trial aims to find out

NCT ID NCT07506148

Symptom relief Sponsor: Mónica Larrosa Signorelli Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study compares two group therapies for university students aged 18-28 who have moderate anxiety and depression. One group receives Acceptance and Commitment Therapy (ACT), which teaches skills to accept difficult emotions and live according to personal values. The other group gets a supportive, non-directive therapy that provides empathy and listening. The goal is to see which approach better reduces emotional symptoms and improves flexibility in thinking. The trial involves 48 participants and uses questionnaires, daily phone surveys, and interviews to measure results.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Acceptance and Commitment Therapy (ACT) - a type of talk therapy that helps people accept difficult feelings and act on what matters to them
What this could lead to
If ACT works better than general support groups, it could give universities an effective, short-term therapy option for students struggling with anxiety and depression.
What could go wrong
This is a small early-stage trial with only 48 students, so results may not apply to everyone. Both groups might improve, making it hard to tell if ACT is truly better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 28 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * University students aged 18 to 28 years. * Score ≥8 on the PHQ-9. * Score ≥8 on the GAD-7. * Willingness to participate in a longitudinal study including pre-, post-, and follow-up assessments. * Willingness to complete daily and weekly ecological momentary assessments (EMA). * Provision of written informed consent. Exclusion Criteria: * Suicide risk based on clinical indicators derived from PHQ-9 assessment. * Self-reported history of psychotic disorders. * Self-reported problematic substance use. * Failure to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Depression depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Depression

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universidad de Montevideo

    RECRUITING

    Montevideo, Montevideo Department, 11600, Uruguay

More trials for these conditions

Other studies related to the condition(s) this trial covers.